2024 Oct 04
New Genetic Signatures Can Classify Breast Cancers and Guide Prognosis
Researchers at Weill Cornell Medicine have developed breast cancer cell-of-origin signatures that can better predict both overall and progression-free survival of patients with breast cancer compared to previously developed... Read more